| scholarly article | Q13442814 |
| P356 | DOI | 10.2337/DIAB.43.12.1494 |
| P953 | full work available at URL | https://journals.org/diabetes/diabetes/article-pdf/43/12/1494/360531/43-12-1494.pdf |
| https://diabetesjournals.org/diabetes/article-pdf/43/12/1494/360531/43-12-1494.pdf | ||
| P698 | PubMed publication ID | 7525393 |
| P2093 | author name string | R. K. Singh | |
| B. Singh | |||
| J. F. Elliott | |||
| D. K. Smith | |||
| J. Lauzon | |||
| H. Y. Qin | |||
| T. Dillon | |||
| S. Bhatti | |||
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1494-1499 | |
| P577 | publication date | 1994-12-01 | |
| P1433 | published in | Diabetes | Q895262 |
| P1476 | title | Immunization with the larger isoform of mouse glutamic acid decarboxylase (GAD67) prevents autoimmune diabetes in NOD mice | |
| Immunization With the Larger Isoform of Mouse Glutamic Acid Decarboxylase (GAD67) Prevents Autoimmune Diabetes in NOD Mice | |||
| P478 | volume | 43 |
| Q34373006 | A role of Hsp60 in autoimmune diabetes: analysis in a transgenic model. |
| Q34508281 | An update on the use of NOD mice to study autoimmune (Type 1) diabetes |
| Q78139069 | Anti-GAD monoclonal antibody delays the onset of diabetes mellitus in NOD mice |
| Q35762883 | Antigen-specific therapeutic approaches in Type 1 diabetes |
| Q34113929 | Autoantigens plus interleukin-10 suppress diabetes autoimmunity |
| Q56908828 | CD28/B7 regulation of Th1 and Th2 subsets in the development of autoimmune diabetes |
| Q36404353 | Cytoplasmic processing is a prerequisite for presentation of an endogenous antigen by major histocompatibility complex class II proteins |
| Q35851189 | Detection of glutamic acid decarboxylase-activated T cells with I-Ag7 tetramers |
| Q36365722 | Dual T cell receptor alpha chain T cells in autoimmunity |
| Q71840947 | From Th1 to Th2: diabetes immunotherapy shifts gears |
| Q42460554 | Glutamate-induced over-expression of GAD is down-regulated by acetyl-L-carnitine in rat islet cells |
| Q54943177 | Immature Dendritic Cell Therapy Confers Durable Immune Modulation in an Antigen-Dependent and Antigen-Independent Manner in Nonobese Diabetic Mice. |
| Q34118450 | Immune mechanisms that regulate susceptibility to autoimmune type I diabetes |
| Q34099969 | Immune therapy for type 1 diabetes mellitus-what is unique about anti-CD3 antibodies? |
| Q34118463 | Immunotherapy of immune-mediated diabetes. Present and future |
| Q37384851 | Induction of insulitis by glutamic acid decarboxylase peptide-specific and HLA-DQ8-restricted CD4(+) T cells from human DQ transgenic mice |
| Q37682917 | Induction of oral tolerance to prevent diabetes with transgenic plants requires glutamic acid decarboxylase (GAD) and IL-4. |
| Q37193763 | Inhibition of Th17 cells regulates autoimmune diabetes in NOD mice. |
| Q71046915 | Insulin-dependent diabetes mellitus |
| Q46345979 | Modulating autoimmune responses to GAD inhibits disease progression and prolongs islet graft survival in diabetes-prone mice |
| Q39774757 | Naturally processed T cell epitopes from human glutamic acid decarboxylase identified using mice transgenic for the type 1 diabetes-associated human MHC class II allele, DRB1*0401. |
| Q37374258 | Neonatal activation of CD28 signaling overcomes T cell anergy and prevents autoimmune diabetes by an IL-4-dependent mechanism. |
| Q37351448 | Persistent suppression of type 1 diabetes by a multicomponent vaccine containing a cholera toxin B subunit-autoantigen fusion protein and complete Freund's adjuvant |
| Q61800640 | Prenatal Betamethasone interferes with immune system development and alters target cells in autoimmune diabetes |
| Q35101668 | Protection against autoimmune diabetes by silkworm-produced GFP-tagged CTB-insulin fusion protein. |
| Q71766096 | Regulation of autoimmune diabetes: characteristics of non-islet-antigen specific therapies |
| Q39505919 | Role of immune system modulation in prevention of type 1 diabetes mellitus |
| Q34629092 | Suppression of dendritic cell activation by diabetes autoantigens linked to the cholera toxin B subunit. |
| Q31066837 | T cells recognize multiple GAD65 and proinsulin epitopes in human type 1 diabetes, suggesting determinant spreading |
| Q37805563 | T-cell autoantigens in the non-obese diabetic mouse model of autoimmune diabetes |
| Q35539014 | The non obese diabetic (NOD) mouse: a unique model for understanding the interaction between genetics and T cell responses |
| Q34452348 | The nonobese diabetic mouse as a model of autoimmune diabetes: immune dysregulation gets the NOD. |
| Q37644601 | Tobacco, a highly efficient green bioreactor for production of therapeutic proteins |
| Q73486424 | Transgenic plants expressing autoantigens fed to mice to induce oral immune tolerance |
| Q37429227 | Transgenically induced GAD tolerance curtails the development of early beta-cell autoreactivities but causes the subsequent development of supernormal autoreactivities to other beta-cell antigens |
| Q37689318 | Viruses, cytokines, antigens, and autoimmunity |
Search more.